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Identity 
Other names: CCN5; rCop-1; CT58; CTGF-L 
HGNC (Hugo): WISP2 
Location: 20q12-13 
Note: WISP-2 is a member of the connective tissue 
growth factor/cysteine-rich 61/nephroblastoma 
overexpressed (nov) (CCN) family and is upregulated 
in the mouse mammary epithelial cell line C57MG 
transformed by Wnt-1 and in several non-invasive 
human breast tumor cell lines.  
WISP-2 is a serum and PMA (phorbol 12-myristate 13-
acetate)-induced early responsive gene. Blocking the 
expression of this gene by WISP-2 antisense oligos or 
siRNA drastically reduce serum or PMA-induced cell 
proliferation in MCF-7 cells. Therefore, these studies 
suggest that WISP-2 signaling may be essential for 
mitogen-induced breast tumor cell proliferation. 
WISP-2 expression is enhanced by important 
modulators of human breast cancer cell proliferation 
such as estrogen, progesterone and epidermal growth 
factor (EGF) in MCF-7 cells. These effects, inhibited 
by appropriate antagonists, indicate that steroids and 
growth factor-induced upregulation of WISP-2 may be 
mediated through receptors. 
The expression profile of WISP-2 gene in breast tumor 
biopsy tissue specimens are similar with that of in vitro 
studies and suggest that WISP-2 mRNA and protein 
levels are significantly higher in tumor samples as 
compared to the normal breast samples, and this 
expression is significantly correlated with the 
expression of estrogen receptor protein. However, 
within the tumor specimens, expression was 
predominant in the non-invasive carcinoma lesions as 
well as benign hyperplastic areas adjacent to the 
invasive tumors. Together, these findings suggest that 
bi-phasic regulation of WISP-2 signaling may be 
critical for initial events of growth, survivability and 
invasion of breast tumor cells. 
WISP-2 also acts as a negative regulator in some cells 
including vascular smooth muscle cells. 
DNA/RNA 
 
Modular structure of individual genes of WISP sub-family of 
CCN family. Module shown with color boxes are the predicted 
primary translational. 
Note 
Until now, three genes have been identified and 
isolated as members of WISP sub-family. WISP-
1/CCN4, WISP-2/CCN5 and WISP-3/CCN6 genes 
were localized in human chromosomes 8q24.1-q24.3, 
20q12-q13 and 6q22-23, respectively and exhibit tissue 
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specific patterns of expression. Nucleotide and protein 
sequence alignment studies have demonstrated a 30-
40% sequence homology within WISP genes and their 
modular architecture is similar except in their C-
terminal domains, which is absent in the WISP-2 gene. 
Protein 
Description 
The translation products of most of the CCN family 
members are secreted proteins of 35-40 kDa and have 
been shown to contain four distinct structural modules: 
1) an IGF-binding protein type (IGFBP) domain, 2) a 
Von Willebrand type C (VWC) domain; 3) a 
Thrombospondin-1 (TSP-1) domain and 4) a C-
terminal Cysteine-knot (CT) domain (10).  
Although the functional roles of these multiple modules 
are unclear, they raise interesting questions as to the 
contribution of each individual module to the biological 
properties of the full-length proteins. 
Expression 
Epithelial cells and vascular smooth muscle cells. 
Localisation 
Adrenal gland, breast, colon, pancreas, uterus and 
ovary. 
Function 
Positive regulator of epithelial cells and negative 
regulator of vascular smooth muscle cells. 
Mutations 
Somatic 







Macronodular adrenal hyperplasia. 
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